摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(9-(3,4-dimethoxyphenyl)-2,2,7,7-tetramethyl-1,8-dioxo-1,2,3,4,5,6,7,8-octahydroacridine-10(9H)-yl)benzenesulfonamide | 1392417-04-7

中文名称
——
中文别名
——
英文名称
4-(9-(3,4-dimethoxyphenyl)-2,2,7,7-tetramethyl-1,8-dioxo-1,2,3,4,5,6,7,8-octahydroacridine-10(9H)-yl)benzenesulfonamide
英文别名
4-(9-(3,4-Dimethoxyphenyl)-2,2,7,7-tetramethyl inverted question mark1,8-dioxo inverted question mark1,2,3,4,5,6,7,8-octahydro acridine inverted question mark10(9H)-yl)benzenesulfonamide (11);4-[9-(3,4-dimethoxyphenyl)-2,2,7,7-tetramethyl-1,8-dioxo-4,5,6,9-tetrahydro-3H-acridin-10-yl]benzenesulfonamide
4-(9-(3,4-dimethoxyphenyl)-2,2,7,7-tetramethyl-1,8-dioxo-1,2,3,4,5,6,7,8-octahydroacridine-10(9H)-yl)benzenesulfonamide化学式
CAS
1392417-04-7
化学式
C31H36N2O6S
mdl
——
分子量
564.703
InChiKey
RVWYHRHTBVXFTN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    40
  • 可旋转键数:
    5
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    124
  • 氢给体数:
    1
  • 氢受体数:
    8

反应信息

  • 作为产物:
    描述:
    4,4-二甲基-1,3-环己二酮3,4-二甲氧基苯甲醛磺胺4-十二烷基苯磺酸 作用下, 以 为溶剂, 反应 10.0h, 以76%的产率得到4-(9-(3,4-dimethoxyphenyl)-2,2,7,7-tetramethyl-1,8-dioxo-1,2,3,4,5,6,7,8-octahydroacridine-10(9H)-yl)benzenesulfonamide
    参考文献:
    名称:
    Synthesis and characterization of novel dioxoacridine sulfonamide derivatives as new carbonic anhydrase inhibitors
    摘要:
    Novel dioxoacridine sulfonamide compounds were synthesized from reaction of cyclic 1,3-diketones, sulfanilamide (4-amino benzene sulfonamide) and aromatic aldehydes. The structures of these compounds were confirmed by using spectral analysis (IR, H-NMR, C-13-NMR, and mass). Human carbonic anhydrase isoenzymes (hCA I and hCA II) were purified from erythrocyte cells by affinity chromatography. The inhibitory effects of sulfanilamide, acetazolamide (AAZ), and newly synthesized sulfonamides on hydratase and esterase activities of these isoenzymes have been studied in vitro. The IC50 values of compounds for esterase activity are 0.71-0.11 mu M for hCA I and 0.45-0.12 mu M for hCA II, respectively. The K-i values of these inhibitors were determined as 0,38-0,008 mu M for hCA I and 0,19-0,001 mu M for hCA II, respectively.
    DOI:
    10.3109/14756366.2011.599029
点击查看最新优质反应信息

文献信息

  • Synthesis and characterization of novel dioxoacridine sulfonamide derivatives as new carbonic anhydrase inhibitors
    作者:Muharrem Kaya、Erhan Basar、Emrah Çakir、Ekrem Tunca、Metin Bülbül
    DOI:10.3109/14756366.2011.599029
    日期:2012.8.1
    Novel dioxoacridine sulfonamide compounds were synthesized from reaction of cyclic 1,3-diketones, sulfanilamide (4-amino benzene sulfonamide) and aromatic aldehydes. The structures of these compounds were confirmed by using spectral analysis (IR, H-NMR, C-13-NMR, and mass). Human carbonic anhydrase isoenzymes (hCA I and hCA II) were purified from erythrocyte cells by affinity chromatography. The inhibitory effects of sulfanilamide, acetazolamide (AAZ), and newly synthesized sulfonamides on hydratase and esterase activities of these isoenzymes have been studied in vitro. The IC50 values of compounds for esterase activity are 0.71-0.11 mu M for hCA I and 0.45-0.12 mu M for hCA II, respectively. The K-i values of these inhibitors were determined as 0,38-0,008 mu M for hCA I and 0,19-0,001 mu M for hCA II, respectively.
查看更多